Treatment remained well-tolerated with consistent injection feasibility in 103 heavily pre-treated patients with R/M-HNSCC naïve or resistant to anti-PD-163% (26/41)…
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French…